Preface | p. x |
Introduction to Drugs and Society | p. 2 |
Introduction | p. 4 |
Drug Use | p. 4 |
Dimensions of Drug Use | p. 5 |
Most Commonly Abused Drugs | p. 14 |
An Overview of Drugs in Society | p. 18 |
How Widespread Is Drug Abuse? | p. 19 |
Extent and Frequency of Drug Use in Society | p. 19 |
Current Patterns of Licit and Illicit Drug Use | p. 28 |
Nonmedical Users of Pain Relievers | p. 28 |
Types of Drug Users | p. 33 |
Influence of the Mass Media on Drug Use | p. 34 |
Drug Use and Drug Dependence | p. 36 |
When Does Use Lead to Abuse? | p. 37 |
Drug Dependence | p. 38 |
The Costs of Drug Use to Society | p. 39 |
Drugs, Crime, and Violence | p. 41 |
Drugs in the Workplace: A Costly Affliction | p. 44 |
Venturing to a Higher Form of Consciousness: The Holistic Self-Awareness Approach to Drug Use | p. 46 |
Explaining Drug Use and Abuse | p. 52 |
Introduction | p. 54 |
Drug Use: A Timeless Affliction | p. 55 |
The Origin and Nature of Addiction | p. 57 |
Defining Addiction | p. 57 |
Models of Addiction | p. 58 |
Factors Contributing to Addiction | p. 59 |
The Vicious Cycle of Addiction | p. 61 |
Nondrug Addictions? | p. 61 |
Major Theoretical Explanations: Biological | p. 62 |
Abused Drugs as Positive Reinforcers | p. 62 |
Drug Abuse and Psychiatric Disorders | p. 63 |
Genetic Explanations | p. 63 |
Major Theoretical Explanations: Psychological | p. 64 |
Distinguishing Between Substance Abuse and Mental Disorders | p. 64 |
The Relationship Between Personality and Drug Use | p. 65 |
Theories Based on Learning Processes | p. 65 |
Social Psychological Learning Theories | p. 67 |
Major Theoretical Explanations: Sociological | p. 67 |
Social Influence Theories | p. 68 |
Structural Influence Theories | p. 78 |
Danger Signals of Drug Abuse | p. 82 |
Low-Risk and High-Risk Drug Choices | p. 63 |
Drug Use, Regulation, and the Law | p. 90 |
Introduction | p. 92 |
Cultural Attitudes About Drug Use | p. 92 |
The Road to Regulation and the FDA | p. 93 |
Prescription Versus OTC Drugs | p. 93 |
The Rising Demand for Effectiveness in Medicinal Drugs | p. 95 |
Regulating the Development of New Drugs | p. 95 |
The Effects of the OTC Review on Today's Medications | p. 98 |
The Regulation of Drug Advertising | p. 98 |
Prescription Advertising | p. 99 |
Federal Regulation and Quality Assurance | p. 99 |
Drug Abuse and the Law | p. 101 |
Drug Laws and Deterrence | p. 103 |
Factors in Controlling Drug Abuse | p. 104 |
Strategies for Preventing Drug Abuse | p. 107 |
Supply Reduction Strategy | p. 107 |
Demand Reduction Strategy | p. 108 |
Inoculation Strategy | p. 108 |
Drug Courts | p. 109 |
Current and Future Drug Use | p. 109 |
Drug Legalization Debate | p. 110 |
Drug Testing | p. 112 |
Pragmatic Drug Policies | p. 113 |
Homeostatic Systems and Drugs | p. 118 |
Introduction | p. 120 |
Overview of Homeostasis and Drug Actions | p. 120 |
Introduction to Nervous Systems | p. 120 |
Comprehensive Explanation of Homeostatic Systems | p. 122 |
The Building Blocks of the Nervous System | p. 122 |
The Neuron: The Basic Structural Unit of the Nervous System | p. 122 |
The Nature of Drug Receptors | p. 124 |
Agonistic and Antagonistic Effects on Drug Receptors | p. 124 |
Neurotransmitters: The Messengers | p. 125 |
Major Divisions of the Nervous System | p. 128 |
The Central Nervous System | p. 129 |
The Autonomic Nervous System | p. 130 |
The Endocrine System | p. 132 |
Endocrine Glands and Regulation | p. 132 |
The Abuse of Hormones: Anabolic Steroids | p. 133 |
Designer Steroids | p. 135 |
Conclusion | p. 135 |
How and Why Drugs Work | p. 138 |
Introduction | p. 140 |
The Intended and Unintended Effects of Drugs | p. 140 |
The Dose-Response Relationship of Therapeutics and Toxicity | p. 141 |
Margin of Safety | p. 142 |
Potency Versus Toxicity | p. 142 |
Drug Interaction | p. 143 |
Additive Effects | p. 143 |
Antagonistic (Inhibitory) Effects | p. 143 |
Potentiative (Synergistic) Effects | p. 144 |
Dealing with Drug Interactions | p. 144 |
Pharmacokinetic Factors That Influence Drug Effects | p. 145 |
Forms and Methods of Taking Drugs | p. 146 |
Distribution of Drugs in the Body and Time-Response Relationships | p. 148 |
Inactivation and Elimination of Drugs from the Body | p. 150 |
Physiological Variables That Modify Drug Effects | p. 151 |
Pathological Variables That Modify Drug Effects | p. 151 |
Adaptive Processes and Drug Abuse | p. 151 |
Tolerance to Drugs | p. 152 |
Drug Dependence | p. 155 |
Psychological Factors | p. 156 |
The Placebo Effect | p. 156 |
Addiction and Abuse: The Significance of Dependence | p. 156 |
Hereditary Factors | p. 157 |
Drug Craving | p. 157 |
Other Factors | p. 158 |
CNS Depressants: Sedative-Hypnotics | p. 162 |
Introduction | p. 164 |
An Introduction to CNS Depressants | p. 164 |
The History of CNS Depressants | p. 164 |
The Effects of CNS Depressants: Benefits and Risks | p. 165 |
Types of CNS Depressants | p. 166 |
Benzodiazepines: Valium-Type Drugs | p. 167 |
Barbiturates | p. 171 |
Other CNS Depressants | p. 173 |
Patterns of Abuse with CNS Depressants | p. 177 |
Treatment for Withdrawal | p. 179 |
Alcohol: Pharmacological Effects | p. 186 |
Introduction | p. 188 |
The Nature and History of Alcohol | p. 189 |
Alcohol as a Drug | p. 189 |
Alcohol as a Social Drug | p. 190 |
Impact of Alcohol | p. 190 |
The Properties of Alcohol | p. 191 |
The Physical Effects of Alcohol | p. 192 |
Alcohol and Tolerance | p. 194 |
Alcohol Metabolism | p. 195 |
Polydrug Use | p. 195 |
Short-Term Effects | p. 195 |
Dependence | p. 197 |
The Effects of Alcohol on Organ Systems and Bodily Functions | p. 198 |
Brain and Nervous System | p. 198 |
Liver | p. 199 |
Digestive System | p. 200 |
Blood | p. 200 |
Cardiovascular System | p. 201 |
Sexual Organs | p. 202 |
Endocrine System | p. 202 |
Kidneys | p. 202 |
Mental Disorders and Damage to the Brain | p. 202 |
The Fetus | p. 202 |
Gender Differences | p. 203 |
Malnutrition | p. 203 |
Alcohol: A Behavioral Perspective | p. 208 |
Introduction | p. 210 |
Alcohol Consumption in the United States | p. 210 |
Current Statistics and Trends in Alcohol Consumption | p. 211 |
Percentages of the Drinking Population: A Pyramid Model | p. 212 |
Economic Costs of Alcohol Abuse | p. 218 |
History of Alcohol in America | p. 220 |
Drinking Patterns | p. 220 |
Historical Considerations | p. 221 |
Defining Alcoholics | p. 221 |
Cultural Differences | p. 225 |
Alcohol Abuse and Alcoholism | p. 226 |
Types of Alcoholics | p. 226 |
Cultural Influences | p. 227 |
Culture and Drinking Behavior | p. 228 |
Culture and Disinhibited Behavior | p. 229 |
Culture Provides Rules for Drinking Behavior | p. 230 |
Culture Provides Ceremonial Meaning for Alcohol Use | p. 230 |
Culture Provides Models of Alcoholism | p. 230 |
Cultural Stereotypes of Drinking Patterns May Be Misleading | p. 231 |
Culture Provides Attitudes Regarding Alcohol Consumption | p. 232 |
College and University Students and Alcohol Use | p. 233 |
Binge Drinking | p. 234 |
Gender and Collegiate Alcohol Use | p. 235 |
Alcohol Consumption Patterns of Women | p. 235 |
The Role of Alcohol in Domestic Violence | p. 237 |
Alcohol and Sex | p. 238 |
Alcohol and the Family: Destructive Types of Support and Organizations for Victims of Alcoholics | p. 238 |
Codependency and Enabling | p. 238 |
Children of Alcoholics (COAs) and Adult Children of Alcoholics (ACOAs) | p. 239 |
Treatment of Alcoholism | p. 239 |
Getting Through Withdrawal | p. 240 |
Helping the Alcoholic Family Recover | p. 241 |
Narcotics (Opioids) | p. 250 |
Introduction | p. 252 |
What Are Narcotics? | p. 252 |
The History of Narcotics | p. 252 |
Opium in China | p. 252 |
American Opium Use | p. 254 |
Pharmacological Effects | p. 256 |
Narcotic Analgesics | p. 256 |
Other Therapeutic Uses | p. 257 |
Mechanisms of Action | p. 258 |
Side Effects | p. 258 |
Abuse, Tolerance, Dependence, and Withdrawal | p. 258 |
Heroin Abuse | p. 259 |
Treatment of Heroin and Other Narcotic Dependence | p. 265 |
Other Narcotics | p. 268 |
Morphine | p. 268 |
Methadone | p. 269 |
Fentanyls | p. 269 |
Hydromorphone | p. 270 |
Oxycodone (OxyContin) | p. 270 |
Meperidine | p. 271 |
Buprenorphine | p. 271 |
MPTP: A "Designer" Tragedy | p. 271 |
Codeine | p. 272 |
Pentazocine | p. 272 |
Propoxyphene | p. 272 |
Narcotic-Related Drugs | p. 272 |
Dextromethorphan | p. 272 |
Clonidine | p. 273 |
Naloxone/Naltrexone | p. 274 |
Stimulants | p. 280 |
Introduction | p. 282 |
Major Stimulants | p. 282 |
Amphetamines | p. 282 |
Cocaine | p. 294 |
Current Attitudes and Patterns of Abuse | p. 299 |
Minor Stimulants | p. 308 |
Caffeinelike Drugs (Xanthines) | p. 308 |
OTC Sympathomimetics | p. 313 |
Herbal Stimulants | p. 313 |
Tobacco | p. 322 |
Tobacco Use: Scope of the Problem | p. 324 |
Current Tobacco Use in the United States | p. 324 |
The History of Tobacco Use | p. 325 |
Popularity in the Western World | p. 325 |
History of Tobacco Use in America | p. 326 |
Phamacology of Nicotine | p. 330 |
Nicotine Administration | p. 330 |
Effects on the Central Nervous System | p. 330 |
Other Effects of Nicotine | p. 330 |
Clove Cigarettes | p. 336 |
Cigarette Smoking: A Costly Addiction | p. 336 |
Mortality Rates | p. 336 |
Chronic Illnesses | p. 337 |
Effects Without Smoking | p. 340 |
Effects on the Fetus | p. 340 |
Tobacco Use Without Smoking | p. 341 |
Environmental Tobacco Smoke | p. 342 |
Who Smokes? | p. 342 |
Reasons for Smoking | p. 343 |
The Motivation Not to Smoke | p. 343 |
Alternative Activities for Successfully Quitting | p. 344 |
Smoking Cessation Aids | p. 344 |
Social Issues: Looking to the Future | p. 346 |
Tobacco as a Gateway Drug | p. 346 |
Smoking Prohibition Versus Smokers' Rights | p. 347 |
Hallucinogens (Psychedelics) | p. 352 |
Introduction | p. 354 |
The History of Hallucinogen Use | p. 354 |
The Native American Church | p. 355 |
Timothy Leary and the League of Spiritual Discovery | p. 355 |
Hallucinogen Use Today | p. 356 |
The Nature of Hallucinogens | p. 356 |
Sensory and Psychological Effects | p. 357 |
Mechanisms of Action | p. 359 |
Types of Hallucinogenic Agents | p. 359 |
Traditional Hallucinogens: LSD Types | p. 360 |
Phenylethylamine Hallucinogens | p. 368 |
Anticholinergic Hallucinogens | p. 370 |
Other Hallucinogens | p. 372 |
Marijuana | p. 382 |
Introduction | p. 384 |
History and Trends in Marijuana Use | p. 385 |
Current Use of Marijuana | p. 388 |
Trends in Use | p. 390 |
Annual Use | p. 392 |
Perceived Harmfulness | p. 392 |
Disapproval | p. 392 |
Perceived Availability, Risk, and Use | p. 392 |
Marijuana: Is It the Assassin of Youth? | p. 293 |
Major Factors Affecting Marijuana Use | p. 393 |
Is Marijuana Really a Gateway Drug? | p. 394 |
Misperceptions of Marijuana Use | p. 395 |
Characteristics of Cannabis | p. 395 |
The Behavioral Effects of Marijuana Use | p. 397 |
The "High" | p. 397 |
Subjective Euphoric Effects | p. 398 |
Driving Performance | p. 400 |
Critical Thinking Skills | p. 401 |
Amotivational Syndrome | p. 401 |
Therapeutic Uses and the Controversy over Medical Marijuana Use | p. 403 |
The Physiological Effects of Marijuana Use | p. 407 |
Effects on the Central Nervous System | p. 407 |
Effects on the Respiratory System | p. 408 |
Effects on the Cardiovascular System | p. 408 |
Effects on Sexual Performance and Reproduction | p. 409 |
Tolerance and Dependence | p. 410 |
Chronic Use | p. 410 |
Inhalants | p. 418 |
Introduction | p. 420 |
History of Inhalants | p. 420 |
Types of Inhalants | p. 421 |
Volatile Substances | p. 421 |
Anesthetics | p. 423 |
Nitrites | p. 424 |
Current Patterns and Signs of Abuse | p. 424 |
Adolescent and Teenage Usage | p. 424 |
Gender, Race, Socioeconomics, and Abuse | p. 425 |
Signs of Inhalant Abuse | p. 426 |
Dangers of Inhalant Abuse | p. 426 |
Over-the-Counter (OTC), Prescription, and Herbal Drugs | p. 430 |
Introduction | p. 432 |
OTC Drugs | p. 432 |
Abuse of OTC Drugs | p. 432 |
Federal Regulation of OTC Drugs | p. 434 |
OTC Drugs and Self-Care | p. 434 |
Types of OTC Drugs | p. 436 |
OTC Herbal (Natural) Products | p. 448 |
Prescription Drugs | p. 451 |
Prescription Drug Abuse | p. 451 |
Proper Doctor-Patient Communication | p. 452 |
Drug Selection: Generic Versus Proprietary | p. 453 |
Common Categories of Prescription Drugs | p. 455 |
Common Principles of Drug Use | p. 462 |
Drug Use Within Major Subcultures | p. 468 |
Introduction | p. 470 |
Athletes and Drug Abuse | p. 471 |
Drugs Used by Athletes | p. 473 |
Prevention and Treatment | p. 482 |
Drug Use Among Women | p. 482 |
Women More Concerned About Drug Use Than Men | p. 483 |
Patterns of Drug Use: Comparing Females with Males | p. 483 |
Female Roles and Drug Addiction | p. 483 |
Women's Response to Drugs | p. 485 |
Treatment of Drug Dependency in Women | p. 488 |
Drug Use in Adolescent Subcultures | p. 489 |
Why Adolescents Use Drugs | p. 490 |
Patterns of Drug Use in Adolescents | p. 492 |
Adolescent versus Adult Drug Abuse | p. 493 |
Consequences and Coincidental Problems | p. 493 |
Prevention, Intervention, and Treatment of Adolescent Drug Problems | p. 498 |
Summary of Adolescent Drug Abuse | p. 500 |
Drug Use in College Student Subcultures | p. 501 |
Reasons for College Students' Drug Use | p. 501 |
Additional Noteworthy Findings Regarding Drug Use by College Students | p. 504 |
HIV and AIDS | p. 506 |
Nature of HIV Infection and Related Symptoms | p. 507 |
Diagnosis and Treatment | p. 507 |
Who Is at Risk for AIDS? | p. 510 |
AIDS and Drugs of Abuse | p. 512 |
Adolescents and AIDS | p. 513 |
What to Do About HIV and AIDS | p. 514 |
The Entertainment Industry and Drug Use | p. 515 |
More Recent Promoter of Drug Use: The Internet | p. 517 |
Drug Abuse Prevention | p. 526 |
Introduction | p. 528 |
Drug Prevention Programs | p. 530 |
Considering the Audience and Approach | p. 530 |
An Example of Drug Prevention at Central High in Elmtown | p. 532 |
Comprehensive Prevention Programs for Drug Use and Abuse | p. 531 |
Harm Reduction Model | p. 534 |
Community-Based Drug Prevention | p. 534 |
School-Based Drug Prevention | p. 535 |
Family-Based Prevention Programs | p. 538 |
Drug Prevention Programs in Higher Education | p. 539 |
Overview and Critique of Existing Prevention Programs | p. 539 |
Examples of Large-Scale Drug Prevention Programs | p. 541 |
BACCHUS and GAMMA Peer Education Network | p. 541 |
Fund for the Improvement of Post-secondary Education Drug Prevention Programs | p. 541 |
DARE (Drug Abuse Resistance Education) | p. 543 |
Drug Courts | p. 543 |
Problems with Assessing the Success of Drug Prevention Programs | p. 546 |
Other Alternatives to Drug Use | p. 546 |
Meditation | p. 547 |
The Natural Mind Approach | p. 549 |
Treating Drug Dependence | p. 554 |
Treatment of Addiction | p. 556 |
Drug Addiction Treatment in the United States | p. 558 |
Therapeutic Strategies | p. 558 |
Historical Approaches | p. 558 |
General Therapeutic Strategies | p. 560 |
Specific Therapeutic Strategies | p. 561 |
Pharmacological Strategies | p. 562 |
Current Trends in Providing Treatment Services | p. 564 |
Appendices | p. 568 |
Index | p. 576 |
Photo Credits | p. 588 |
Table of Contents provided by Ingram. All Rights Reserved. |
The New copy of this book will include any supplemental materials advertised. Please check the title of the book to determine if it should include any access cards, study guides, lab manuals, CDs, etc.
The Used, Rental and eBook copies of this book are not guaranteed to include any supplemental materials. Typically, only the book itself is included. This is true even if the title states it includes any access cards, study guides, lab manuals, CDs, etc.